Skip to main content

Table 1 Changes in BCVA, visual field MD and ORT values after WJ-MSC applications in 34 eyes (32 patients)

From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results

NoEyeBCVAVisual field MDOuter Retinal Thickness
BeforeAfterBeforeAfterBeforeAfter
1Ri10011028,327,785.0152.2
2Li808728,026,693.4120.4
3Rc808828,327,3117.4117.8
4Lc848828,226,7118.2145.4
5Lc507429,226,1103.0105.7
6Lc808528,925,8129.0131.9
7Rc505619.49,4116.0126.3
8Lc808727,626,4101.4102.2
9Li727925,319,279.2135.6
10Li505518,714,4105.0111.8
11Rc657729,228,192.2128.7
12Ri657429,628,8128.2145.6
13Li658728,025,7101.0104.8
14Rc506919,55,7100.4110.0
15Li8911028,416,484.8120.0
16Ri808328,928,2128.698.4
17Lc505929,129,0105.6122.8
18Lc808528,627,389.094.8
19Ri506526,123,982.6109.0
20Rc607713,913,384.286.8
21Rc505929,929,485.297.0
22Li778728,627,586.0116.0
23Ri707025,525,691.091.6
24Li9811026,125,9118.2152.4
25Lc859129,128,9106.0132.8
26Lc8911025,923,2109.3122.0
27Ri859428,828,7120.2135.8
28Ri505528,527,9116.0122.8
29Rc505029,429,4117.0117.0
30Li899427,425,2110.0140.4
31Rc748528,927,6101.0106.0
 Li808728,628,196.9101.3
32Rc607729,429,470.4111.8
 Li607728,127,772.6112.4
  1. BCVA best-corrected visual acuity, ETDRS early treatment of diabetic retinopathy study charts (letters point);
  2. MD mean deviation (dB)
  3. Outer retinal thickness (μm)
  4. i: injection by 25 G sharp-tip needle
  5. c: application by subtenon curved canulla with preplaced suture